Smith & Nephew is an industry leader in each of our three main Global Business Units - Orthopaedic Reconstruction and Trauma, Endoscopy and Advanced Wound Management. These businesses jointly offer over 1,000 product ranges.

Our global infrastructure continues to expand each year. We currently operate in 32 countries and generate annual sales of $3.4 billion. Substantial investment in our products and intensive research and development means that we are always ahead. Figures from last year show that we stand at number one as the leading company in Arthroscopy. We are the second largest organisation in Advanced Wound Management and number three in Trauma and Clinical Therapies. We are also positioned at number four in reconstruction.

Smith & Nephew has a track record of bringing innovative new products to market that provide better clinical outcomes for patients and save costs for healthcare providers. This is the primary focus of our fourth business unit, Biologics.

Show more
Type
Public
HQ
London, GB
Founded
1856
Size (employees)
15,000 (est)
Smith & Nephew was founded in 1856 and is headquartered in London, GB
Report incorrect company information

Key People/Management at Smith & Nephew

Olivier Bohuon

Olivier Bohuon

CEO
Graham Baker

Graham Baker

CFO
John W. Campo

John W. Campo

CLO
Helen Maye

Helen Maye

Chro
Philippe Mazas

Philippe Mazas

Group CIO
Show more

Smith & Nephew Office Locations

Smith & Nephew has offices in Austin, St. Petersburg, Memphis, Andover and in 4 other locations
London, GB (HQ)
15 Adam Street
São Paulo, BR
Av. do Café, 277
Andover, US
150 Minuteman Road
Austin, US
7000 W William Cannon Dr.
Durham, US
4721 Emperor Blvd. Suite 100
Fort Worth, US
3909 Hulen Street
Show all (8)
Report incorrect company information

Smith & Nephew Financials and Metrics

Smith & Nephew Revenue

Embed Graph
Smith & Nephew's revenue was reported to be £3.46 b in FY, 2017
GBP

Revenue (FY, 2017)

3.5 b

Gross profit (FY, 2017)

2.6 b

Gross profit margin (FY, 2017), %

73.8%

Net income (FY, 2017)

556.8 m

EBITDA (FY, 2017)

993.8 m

EBIT (FY, 2017)

678 m

Market capitalization (16-Aug-2018)

212.5 m

Closing stock price (16-Aug-2018)

2.4

Cash (31-Dec-2017)

122.7 m

EV

109.4 m
Smith & Nephew's current market capitalization is $212.5 m.
GBPFY, 1996FY, 1997FY, 1998FY, 1999FY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

1.1 b1 b1.1 b1.1 b1.1 b1.1 b1.1 b1.2 b1.2 b1.4 b1.4 b2 b2.9 b3.2 b3.6 b3.4 b3.5 b

Revenue growth, %

11%0%13%

Cost of goods sold

472.6 m446.1 m453.3 m479.6 m456.8 m350.2 m329.9 m345.1 m334.8 m361 m1.1 b600.7 m724.8 m797.5 m883.4 m923.3 m905.9 m

Gross profit

596.6 m602 m600.1 m640.3 m677.9 m731.5 m780 m833.8 m913.7 m1 b292 m1.4 b2.1 b2.4 b2.7 b2.5 b2.6 b
GBPFY, 1996FY, 1997FY, 1998FY, 1999FY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

80.5 m57.1 m49.9 m100.5 m24.6 m30 m22.5 m26 m32.6 m88 m177 m102.7 m90.3 m63.8 m92.8 m72.6 m122.7 m

Accounts Receivable

218.7 m219.9 m233.1 m241.8 m246.2 m224.4 m222.6 m246 m273.5 m323 m322 m468.3 m616.1 m664.3 m751.3 m717.2 m766.6 m

Inventories

229.8 m225.7 m242.4 m237.6 m228.2 m232.2 m229.5 m230.6 m284.9 m355 m316 m504 m662.8 m810.5 m940.6 m903 m946.6 m

Current Assets

564.5 m561.3 m570.9 m619.2 m530.6 m525.4 m532.7 m591.1 m679.3 m937 m840 m1.2 b1.5 b1.7 b1.9 b1.8 b2 b
GBPFY, 1996FY, 1997FY, 1998FY, 1999FY, 2000FY, 2001FY, 2002FY, 2003FY, 2004FY, 2005FY, 2006FY, 2007FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

120.7 m113.7 m93.7 m104.8 m205.2 m129.6 m112.1 m148.1 m125.2 m170 m201 m191 m366.3 m343.8 m316.9 m569.1 m556.8 m

Cash From Operating Activities

189.3 m181.7 m161.9 m198.1 m204 m191.9 m209.3 m214.5 m226.6 m147 m190 m264.7 m571.3 m468.7 m796.1 m616.3 m791.2 m

Dividends Paid

66.5 m69 m69.2 m72.5 m456.9 m42.9 m44.6 m46.1 m47.8 m50 m49 m62.8 m157.5 m164 m202.5 m195.3 m

Cash From Financing Activities

40.4 m(19.7 m)158.7 m17.8 m94.8 m(93.1 m)(16.9 m)(22 m)(196 m)209.7 m(328.1 m)691.8 m(431.3 m)(384 m)(315 m)
GBPY, 2017

EV/EBITDA

0.1 x

EV/EBIT

0.2 x

EV/CFO

0.1 x

Revenue/Employee

228.4 k

Financial Leverage

1.7 x
Show all financial metrics

Smith & Nephew Operating Metrics

Smith & Nephew's Training Provided, no. of people was reported to be 90 k in FY, 2016.
FY, 2016

Training Provided, no. of people

90 k
Show all operating metrics

Smith & Nephew Revenue Breakdown

Embed Graph

Smith & Nephew revenue breakdown by business segment: 12.9% from Sports Medicine Joint Repair , 13.9% from Arthroscopic Enabling Technologies , 9.9% from Trauma & Extremities, 19.8% from Knee Implants, 12.9% from Hip Implants, 14.9% from Advanced Wound Care, 6.9% from Advanced Wound Bioactives and 8.9% from Other

Report incorrect company information

Smith & Nephew Online and Social Media Presence

Embed Graph
Report incorrect company information

Smith & Nephew News and Updates

New Research Study on Knee Implants Market: Key Players involved in the research - B. Braun, Smith & Nephew, Zimmer Biomet Holding Inc., Stryker

HTF MI recently launched the Global Knee Implants study with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. Posted via Industry Today. Follow us on Twitter @IndustryToday

Pappas Capital sells Rotation Medical to Smith & Nephew

Smith & Nephew plc has acquired Plymouth, Minnesota-based Rotation Medical, a developer of treatments for rotator cuff disease, for an initial cash consideration of $125 million. The seller was Pappas Capital.
Report incorrect company information

Smith & Nephew Company Life and Culture

Report incorrect company information